A novel vascular endothelial growth factor-directed therapy that selectively activates cytotoxic prodrugs

por Spooner, R A, Friedlos, F, Maycroft, K, Stribbling, S M, Roussel, J, Brueggen, J, Stolz, B, O'Reilly, T, Wood, J, Matter, A, Marais, R, Springer, C J
Publicado 2003